ActivePhase 1ACTRN12606000035527

Recurrence of varicose veins following superficial venous surgery - mechanism and prevention.


Sponsor

Department of Surgery, Dunedin School of Medicine

Enrollment

180 participants

Start Date

Jun 1, 1999

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 16 YearssMax Age: 75 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Recurrence of varicose veins following superficial venous surgery - mechanism and prevention.. You may be eligible if you are people aged 16 to 75 with clear indication for superficial cein surgery (primary or recurrent)- reasonable expectation for good compliance over study period. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A randomised controlled prospective study of the use of a mechanical barrier to prevent neovascularisation recurrence of varicose veins following surgery. Two groups will be compared. - Group A: Comp

A randomised controlled prospective study of the use of a mechanical barrier to prevent neovascularisation recurrence of varicose veins following surgery. Two groups will be compared. - Group A: Complete surgical correction of venous reflux based on duplex ultrasound mapping and routine surgical techniques. - Group B: Treatment group: As for Group A plus surgical patch (PTFE) placed over the ligated saphenofemoral junction to obstruct new vessel formation. - Follow up of all patients (ultrasound, air plethysmography and clinical evaluation) for 5 years: 1 month, 6 months, 1 year, 3 years and 5 years.


Locations(1)

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000035527


Related Trials